These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8649955)
1. [Evaluation of nonspecific inflammatory bowel disease in children using disease activity scoring systems]. Ryzko J; Woynarowski M Pediatr Pol; 1995 Jul; 70(7):569-73. PubMed ID: 8649955 [TBL] [Abstract][Full Text] [Related]
2. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Vucelic B Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751 [TBL] [Abstract][Full Text] [Related]
4. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease. Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864 [TBL] [Abstract][Full Text] [Related]
5. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A; Gasiorowska A; Małecka-Panas E Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341 [TBL] [Abstract][Full Text] [Related]
8. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784 [TBL] [Abstract][Full Text] [Related]
9. Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children. Romano C; Famiani A; Gallizzi R; Comito D; Ferrau' V; Rossi P Pediatrics; 2008 Dec; 122(6):e1278-81. PubMed ID: 19047226 [TBL] [Abstract][Full Text] [Related]
10. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Herrlinger KR; Noftz MK; Dalhoff K; Ludwig D; Stange EF; Fellermann K Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276 [TBL] [Abstract][Full Text] [Related]
13. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108 [TBL] [Abstract][Full Text] [Related]
16. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859 [TBL] [Abstract][Full Text] [Related]
17. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease? Zissis M; Afroudakis A; Galanopoulos G; Palermos L; Boura X; Michopoulos S; Archimandritis A Am J Gastroenterol; 2001 Jul; 96(7):2177-83. PubMed ID: 11467650 [TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of inflammatory bowel disease. Wong A; Bass D Curr Opin Pediatr; 2008 Oct; 20(5):566-70. PubMed ID: 18781120 [TBL] [Abstract][Full Text] [Related]
19. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease. Lemberg DA; Clarkson CM; Bohane TD; Day AS J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188 [TBL] [Abstract][Full Text] [Related]
20. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. Abad E; Tural C; Mirapeix E; Cuxart A J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]